Literature DB >> 23670531

Changes in helical content or net charge of apolipoprotein C-I alter its affinity for lipid/water interfaces.

Nathan L Meyers1, Libo Wang, Olga Gursky, Donald M Small.   

Abstract

Amphipathic α-helices mediate binding of exchangeable apolipoproteins to lipoproteins. To probe the role of α-helical structure in protein-lipid interactions, we used oil-drop tensiometry to characterize the interfacial behavior of apolipoprotein C-I (apoC-I) variants at triolein/water (TO/W) and 1-palmitoyl-2-oleoylphosphatidylcholine/triolein/water (POPC/TO/W) interfaces. ApoC-I, the smallest apolipoprotein, has two amphipathic α-helices. Mutants had single Pro or Ala substitutions that resulted in large differences in helical content in solution and on phospholipids. The ability of apoC-I to bind TO/W and POPC/TO/W interfaces correlated strongly with α-helical propensity. On binding these interfaces, peptides with higher helical propensity increased surface pressure to a greater extent. Likewise, peptide exclusion pressure at POPC/TO/W interfaces increased with greater helical propensity. ApoC-I retention on TO/W and POPC/TO/W interfaces correlated strongly with phospholipid-bound helical content. On compression of these interfaces, peptides with higher helical content were ejected at higher pressures. Substitution of Arg for Pro in the N-terminal α-helix altered net charge and reduced apoC-I affinity for POPC/TO/W interfaces. Our results suggest that peptide-lipid interactions drive α-helix binding to and retention on lipoproteins. Point mutations in small apolipoproteins could significantly change α-helical propensity or charge, thereby disrupting protein-lipid interactions and preventing the proteins from regulating lipoprotein catabolism at high surface pressures.

Entities:  

Keywords:  drop tensiometry; protein-lipid interaction; surface chemistry

Mesh:

Substances:

Year:  2013        PMID: 23670531      PMCID: PMC3679394          DOI: 10.1194/jlr.M037531

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  57 in total

Review 1.  High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.

Authors:  A von Eckardstein; J R Nofer; G Assmann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

Review 2.  Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.

Authors:  M C Jong; M H Hofker; L M Havekes
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

Review 3.  Thermodynamics of lipid-peptide interactions.

Authors:  Joachim Seelig
Journal:  Biochim Biophys Acta       Date:  2004-11-03

4.  Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid.

Authors:  B Lu; J A Morrow; K H Weisgraber
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

5.  Probing the conformation of a human apolipoprotein C-1 by amino acid substitutions and trimethylamine-N-oxide.

Authors:  O Gursky
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

6.  Conformation of human apolipoprotein C-I in a lipid-mimetic environment determined by CD and NMR spectroscopy.

Authors:  A Rozek; J T Sparrow; K H Weisgraber; R J Cushley
Journal:  Biochemistry       Date:  1999-11-02       Impact factor: 3.162

7.  Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.

Authors:  David Masson; Jean-Paul Pais de Barros; Zoulika Zak; Thomas Gautier; Naig Le Guern; Mahfoud Assem; Jeffrey W Chisholm; James R Paterniti; Laurent Lagrost
Journal:  J Lipid Res       Date:  2005-11-10       Impact factor: 5.922

8.  Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity.

Authors:  T Gautier; D Masson; J P de Barros; A Athias; P Gambert; D Aunis; M H Metz-Boutigue; L Lagrost
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

9.  The interfacial properties of ApoA-I and an amphipathic alpha-helix consensus peptide of exchangeable apolipoproteins at the triolein/water interface.

Authors:  Libo Wang; David Atkinson; Donald M Small
Journal:  J Biol Chem       Date:  2005-02-11       Impact factor: 5.157

10.  Role of secondary structure in protein-phospholipid surface interactions: reconstitution and denaturation of apolipoprotein C-I:DMPC complexes.

Authors:  Sangeeta Benjwal; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2007-03-07       Impact factor: 3.162

View more
  6 in total

1.  Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition.

Authors:  Nathan L Meyers; Mikael Larsson; Evelina Vorrsjö; Gunilla Olivecrona; Donald M Small
Journal:  J Lipid Res       Date:  2017-02-03       Impact factor: 5.922

2.  Proteogenomic Review of the Changes in Primate apoC-I during Evolution.

Authors:  Donald Puppione; Julian P Whitelegge
Journal:  Front Biol (Beijing)       Date:  2013-10-02

3.  A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II.

Authors:  Nathan L Meyers; Mikael Larsson; Gunilla Olivecrona; Donald M Small
Journal:  J Biol Chem       Date:  2015-05-29       Impact factor: 5.157

4.  Surface behavior of apolipoprotein A-I and its deletion mutants at model lipoprotein interfaces.

Authors:  Libo Wang; Xiaohu Mei; David Atkinson; Donald M Small
Journal:  J Lipid Res       Date:  2013-12-05       Impact factor: 5.922

Review 5.  Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.

Authors:  Elena V Fuior; Anca V Gafencu
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

6.  Dual binding motifs underpin the hierarchical association of perilipins1-3 with lipid droplets.

Authors:  Dalila Ajjaji; Kalthoum Ben M'barek; Michael L Mimmack; Cheryl England; Haya Herscovitz; Liang Dong; Richard G Kay; Satish Patel; Vladimir Saudek; Donald M Small; David B Savage; Abdou Rachid Thiam
Journal:  Mol Biol Cell       Date:  2019-01-16       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.